Skip to main content
Clinical Trials/ACTRN12624001191583
ACTRN12624001191583
Not yet recruiting
未知

Impact of Personalised Exercise Rehabilitation FOR people with Multimorbidity and cardiac or pulmonary disease on quality of life compared to standard cardiac and pulmonary rehabilitation: The PERFORM-CPR trial

Monash University0 sites604 target enrollmentSeptember 30, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Post myocardial infarction
Sponsor
Monash University
Enrollment
604
Primary Endpoint
Health-related quality of life [EQ-5D-5L. Baseline and end intervention (3 months)]
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 yearsAble and willing to provide informed consentIndependently ambulant (including the use of walking aids) Scores in the modified Medical Research Council dyspnoea scale => 2 OR New York Heart Association classification => II Cardiac or pulmonary chronic conditions such as post myocardial infarction, post cardiac revascularization, stable angina, heart failure, COPD, bronchiectasis, and asthmaIn addition, one of the following long-term health conditions: - arthritis- atrial fibrillation- cancer- chronic kidney disease- connective tissue disease (pain)- mild dementia (less than or equal to four errors in the Short Portable Mental Status Questionnaire)- depression- diabetes mellitus- hypertension,- long-COVID- multiple sclerosis- osteoporosis- painful condition due to chronic musculoskeletal conditions: osteoarthritis (hand, hip, and knee), chronic back and neck pain, shoulder impingement, and rotator cuff degeneration- Parkinson’s disease- peripheral vascular disease- polycystic ovarian syndrome- psychoactive substance misuse- stroke or transient ischaemic attack. Patients can also have one of the following conditions from the list below:- anorexia nervosa or bulimia- anxiety- atrial fibrillation- chronic fatigue syndrome- chronic liver disease- chronic sinusitis- diverticular disease- endometriosis, epilepsy- glaucoma- inflammatory bowel disease- irritable bowel syndrome- Meniere’s disease- migraines- pernicious anaemia- prostate disorders- psoriasis or eczema- schizophrenia or bipolar affective disorder- thyroid disease- treated constipation- treated dyspepsia- viral hepatitis

Exclusion Criteria

  • Unable to communicate in EnglishKnown contraindications to exercise (as defined by the American College of Sports Medicine, Ed. 2021): unstable cardiac disease, current fever, and significant aortic aneurysm (more than 5.5 cm).Unable to attend in-person training sessions Participation in a exercised rehabilitation programme in the last 6 months Unstable psychiatric disorder that limits or disrupts group based interventions Active malignancy (on chemotherapy/radiotherapy/planned urgent surgery) with a prognosis of less than 12 months survivalPregnancyLiving in a residential aged care facilityUnsafe to exercise in a group without 1:1 supervision (e.g. significant risk of falls)

Outcomes

Primary Outcomes

Health-related quality of life [EQ-5D-5L. Baseline and end intervention (3 months)]

Similar Trials